140 related articles for article (PubMed ID: 35654819)
1. Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms.
Ernst P; Schnöder TM; Huber N; Perner F; Jayavelu AK; Eifert T; Hsu CJ; Tubío-Santamaría N; Crodel CC; Ungelenk M; Hübner CA; Clement JH; Hochhaus A; Heidel FH
Leukemia; 2022 Jul; 36(7):1843-1849. PubMed ID: 35654819
[TBL] [Abstract][Full Text] [Related]
2. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.
Kim H; Kim D; Choi SA; Kim CR; Oh SK; Pyo KE; Kim J; Lee SH; Yoon JB; Zhang Y; Baek SH
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11766-11771. PubMed ID: 30377265
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
[TBL] [Abstract][Full Text] [Related]
4. Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth.
Gregory BL; Cheung VG
Genome Res; 2014 Jan; 24(1):52-63. PubMed ID: 24285722
[TBL] [Abstract][Full Text] [Related]
5. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.
Lopez C; Schleussner N; Bernhart SH; Kleinheinz K; Sungalee S; Sczakiel HL; Kretzmer H; Toprak UH; Glaser S; Wagener R; Ammerpohl O; Bens S; Giefing M; Sanchez JCG; Apic G; Hubschmann D; Janz M; Kreuz M; Mottok A; Muller JM; Seufert J; Hoffmann S; Korbel JO; Russell RB; Schule R; Trumper L; Klapper W; Radlwimmer B; Lichter P; Kuppers R; Schlesner M; Mathas S; Siebert R
Haematologica; 2023 Feb; 108(2):543-554. PubMed ID: 35522148
[TBL] [Abstract][Full Text] [Related]
6. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder.
Kato H; Kushima I; Mori D; Yoshimi A; Aleksic B; Nawa Y; Toyama M; Furuta S; Yu Y; Ishizuka K; Kimura H; Arioka Y; Tsujimura K; Morikawa M; Okada T; Inada T; Nakatochi M; Shinjo K; Kondo Y; Kaibuchi K; Funabiki Y; Kimura R; Suzuki T; Yamakawa K; Ikeda M; Iwata N; Takahashi T; Suzuki M; Okahisa Y; Takaki M; Egawa J; Someya T; Ozaki N
Transl Psychiatry; 2020 Dec; 10(1):421. PubMed ID: 33279929
[TBL] [Abstract][Full Text] [Related]
7. Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype.
Katainen R; Donner I; Räisänen M; Berta D; Kuosmanen A; Kaasinen E; Hietala M; Aaltonen LA
J Med Genet; 2022 Jul; 59(7):644-651. PubMed ID: 34281993
[TBL] [Abstract][Full Text] [Related]
8. Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury.
Pan HC; Chen YH; Fang WC; Wu VC; Sun CY
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012577
[TBL] [Abstract][Full Text] [Related]
9. Substrate- and cofactor-independent inhibition of histone demethylase KDM4C.
Leurs U; Lohse B; Rand KD; Ming S; Riise ES; Cole PA; Kristensen JL; Clausen RP
ACS Chem Biol; 2014 Sep; 9(9):2131-8. PubMed ID: 25014588
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Jayavelu AK; Schnöder TM; Perner F; Herzog C; Meiler A; Krishnamoorthy G; Huber N; Mohr J; Edelmann-Stephan B; Austin R; Brandt S; Palandri F; Schröder N; Isermann B; Edlich F; Sinha AU; Ungelenk M; Hübner CA; Zeiser R; Rahmig S; Waskow C; Coldham I; Ernst T; Hochhaus A; Jilg S; Jost PJ; Mullally A; Bullinger L; Mertens PR; Lane SW; Mann M; Heidel FH
Nature; 2020 Dec; 588(7836):157-163. PubMed ID: 33239784
[TBL] [Abstract][Full Text] [Related]
11. Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies.
Scott LM; Gandhi MK
Blood Rev; 2015 Nov; 29(6):405-15. PubMed ID: 26123794
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
Young LC; Hendzel MJ
Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
[TBL] [Abstract][Full Text] [Related]
13. Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
Kristensen JB; Nielsen AL; Jørgensen L; Kristensen LH; Helgstrand C; Juknaite L; Kristensen JL; Kastrup JS; Clausen RP; Olsen L; Gajhede M
FEBS Lett; 2011 Jun; 585(12):1951-6. PubMed ID: 21575637
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
[TBL] [Abstract][Full Text] [Related]
15. The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2
Staehle AM; Peeken JC; Vladimirov G; Hoeness ME; Bojtine Kovacs S; Karantzelis N; Gruender A; Koellerer C; Jutzi JS; Pahl HL; Staehle HF
Leukemia; 2023 Apr; 37(4):919-923. PubMed ID: 36709354
[TBL] [Abstract][Full Text] [Related]
16. Histone Demethylases KDM4A and KDM4C Regulate Differentiation of Embryonic Stem Cells to Endothelial Cells.
Wu L; Wary KK; Revskoy S; Gao X; Tsang K; Komarova YA; Rehman J; Malik AB
Stem Cell Reports; 2015 Jul; 5(1):10-21. PubMed ID: 26120059
[TBL] [Abstract][Full Text] [Related]
17. The KDM4A/KDM4C/NF-κB and WDR5 epigenetic cascade regulates the activation of B cells.
Hung KH; Woo YH; Lin IY; Liu CH; Wang LC; Chen HY; Chiang BL; Lin KI
Nucleic Acids Res; 2018 Jun; 46(11):5547-5560. PubMed ID: 29718303
[TBL] [Abstract][Full Text] [Related]
18. KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism.
Zhao E; Ding J; Xia Y; Liu M; Ye B; Choi JH; Yan C; Dong Z; Huang S; Zha Y; Yang L; Cui H; Ding HF
Cell Rep; 2016 Jan; 14(3):506-519. PubMed ID: 26774480
[TBL] [Abstract][Full Text] [Related]
19. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
20. Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes.
Chopra A; Adhikary H; Willmore WG; Biggar KK
Curr Protein Pept Sci; 2020; 21(7):642-654. PubMed ID: 31889485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
